Alzheimer Society of Ontario launches letter writing campaign to ensure patient and caregiver voices are heard.

By Gazette Staff

May 27th, 2026

BURLINGTON, ON

Recent public opinion polling data that shows 82% of Canadians say delaying Alzheimer’s progression by just one year is “priceless” – and yet many still can’t access disease-modifying therapies for early Alzheimer’s.

With 1 in 3 Canadians having cared for someone with Alzheimer’s, this is not a small issue — it’s something affecting millions of families across the country.

The data also points to growing concern around access, with 7 in 10 Ontarians saying that if these treatments are not made available, it reflects poorly on how seriously their government prioritizes healthcare.

This is exactly the gap that caregivers who deal with when taking care of early‑onset Alzheimer’s disease.

• The human impact of slowing disease progression and what ‘extra time’ means for families
• Why equitable access to disease‑modifying therapies is critical and why it matters now

This is why the Alzheimer Society of Ontario has launched a letter writing campaign to ensure patient and caregiver voices are heard.